The Bioplasm 9D NLS belongs to a
class of devices that can be used to assess your risk of diseases at the
pre-clincal stage. It has also therapeutic value in treatment of these
pre-clinical problems, to prevent their degeneration into disease stage. In
other words, it is very useful both for sub-health state screening and
therapy.
This is an example
of how to use the device....A recent piece of research shows:
Damage to the brain's white matter may be an early sign of certain types of Alzheimer's disease, according to a new study.
"Alzheimer's is a gray matter disease. However, white matter damage has a central role in how the disease strikes and progresses," study co-author Dr. Federica Agosta, from the Neuroimaging Research Unit at the San Raffaele Scientific Institute in Milan, Italy, said in a news release from the Radiological Society of North America.
The findings support the theory that Alzheimer's disease may travel along white matter fibers from one area of the brain to another, according to Agosta.
"In early onset AD [Alzheimer's disease] and atypical AD forms, white matter degeneration may be an early marker that precedes gray matter atrophy," she said. "
Because t
here is not much structural damage
in the early stages of focal Alzheimer's disease, there is a risk that patients
may be misdiagnosed."
[Highly recommended article -
on relationship between white matter and autism and anxiety
disorders]
Bioplasm
Usage
You can use the items in the
device: "Gray matter of cerebrum" and "White substance" to analyse if these
brain areas have energetic anomalies. If they do, then it means they are not
healthy and risk degeneration. Then you can use treatments to target your brain
and, at the same time, use the bioresonance Metatherapy function to improve the
brain cell health. The device can help you track if these treatments and therapy
are effective in improving these areas.
没有评论:
发表评论